Physician profile
Adam Smith
NPI 1033109608
$62,183.71
in general payments reported to CMS, 2019-2025
24 companies · $2,313 in 2025
The $2,313 reported for 2025 was more than what 95% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $286 · 2020: $77.35 · 2021: $22K · 2022: $14K · 2023: $23K · 2024: $1,551 · 2025: $2,313.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $22K · Food and Beverage: $2,386 · Travel and Lodging: $1,354 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $700.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $22,000.00 |
| Food and Beverage | $2,386.30 |
| Travel and Lodging | $1,354.22 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $700.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $57,937.09 | 2020-2025 | |
| Reshape Lifesciences INC. | $1,200.33 | 2019-2024 | |
| Medical Device Business Services, INC. | $1,047.48 | 2024 | Echelon Flex |
| Lucid Diagnostics INC. | $391.58 | 2022-2024 | |
| Apollo Endosurgery US INC | $257.79 | 2021-2023 | Overstitch Endoscopic Suturing System |
| Ethicon US, LLC | $216.09 | 2019-2025 | Echelon; Endopath, Harmonic |
| Medtronic, INC. | $158.02 | 2022-2023 | Ligasure |
| Phathom Pharmaceuticals, INC. | $127.05 | 2024-2025 | Voquezna |
| Lexington Medical, INC. | $110.91 | 2024 | Aeon Endostapler & Echelon Flex Powered Stapler |
| Intra-Sana Laboratories | $107.21 | 2025 | Reltone 400 Mg, Glycate, Reltone 200 Mg |
| Alnylam Pharmaceuticals INC. | $107.02 | 2021 | |
| Baxter Healthcare | $93.06 | 2019-2024 | Tisseel |
| Novo Nordisk INC | $85.44 | 2019-2025 | Wegovy |
| Abbott Laboratories | $66.95 | 2019-2021 | |
| Covidien LP | $48.40 | 2019 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tela Bio, INC. | $45.28 | 2024 | Ovitex 2s |
| Currax Pharmaceuticals LLC | $39.35 | 2019-2020 | |
| Pacira Pharmaceuticals Incorporated | $29.26 | 2021 | |
| Abbvie INC. | $23.20 | 2021 | |
| Avanos Medical | $20.42 | 2021 | |
| Boston Scientific Corporation | $19.93 | 2024 | |
| Olympus America INC. | $19.82 | 2020 | |
| Lilly USA, LLC | $17.59 | 2025 | Mounjaro, Zepbound |
| Endo Pharmaceuticals INC. | $14.44 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adam Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.